Region 4 Genetics Collaborative NCC/RC Annual Meeting November 17, 2009 Region 4 Genetics Collaborative Long-term Follow-up Projects.

Slides:



Advertisements
Similar presentations
Mass Screening Using Tandem Mass Spectrometry: Friend or Foe?
Advertisements

Alterations in Metabolic Status Jan Bazner-Chandler RN, MSN, CNS, CPNP.
1 Chapter 43 Inborn Metabolic Defects of Lysosomes, Peroxisomes, Carbohydrates, Fatty Acids and Mitochondria Copyright © 2012, American Society for Neurochemistry.
Newborn Screening in Texas Jann Melton-Kissel Susan U. Neill.
Acyl carnitine analysis: Pitfalls & Problems
Medium chain acyl CoA dehydrogenase deficiencyMCADD June 28, 2011 APHL-CDC Carlos A. Saavedra-Matiz, MD Newborn Screening Program Wadsworth Center New.
The Newborn Screening Quality Assurance Program. W. Harry Hannon, Ph.D. Chief, Newborn Screening Branch Centers for Disease Control and Prevention.
Carol Greene, MD U of Maryland School of Medicine.
Lipids Metabolism. Fatty acids TAG Complete oxidation of fatty acids to CO2 & H2O: 9 Kcal/gram of fat Fatty acids: are stored in adipose tissue, in the.
 Newborn Screening Baylor College of Medicine Anoop Agrawal, M.D.
NBSTRN Update NCC/RC PI/PD Meeting November 19, 2010 Michael Watson.
Pediatric Continuity Clinic Curriculum Created by: Ranjit Shenoy
Recent Expansion of Newborn Screening R. Rodney Howell, M. D. Professor of Pediatrics Miller School of Medicine University of Miami Founding Chair Secretary's.
PLANNING FOR LONG-TERM FOLLOW-UP DATA COLLECTION AFTER NEWBORN SCREENING TO ADVANCE RESEARCH AND IMPROVE SERVICE DELIVERY AND HEALTH OUTCOMES Susan A.
Genetic testing Biochemical genetic testing Cytogenetic testing Direct genetic testing Diagnostic testing Predictive testing Carrier testing Prenatal testing.
Chapter 11 Newborn Screening. Introduction Newborns can be screened for an increasing variety of conditions on the principle that early detection can.
AMCHP 2005 Conference Linking Public Health Databases: Developing Partnerships, Infrastructure, and Testing David Hollar, Michael Copeland, Carmen Lozzio,
National Center for Environmental Health Centers for Disease Control and Prevention Carla D. Cuthbert, Ph.D. Chief, Newborn Screening and Molecular Biology.
VLDL formation Apolipoprotien B-100 has a repeating  -helix/  -sheet structure: Lipids are packaged as apolipoprotein B-100 is being synthesized: From.
Newborn Screening via Tandem Mass Spectrometry, Michigan, 2006 Steven Korzeniewski, MS, MA, William Young, PhD, and Violanda Grigorescu, MD, MSPH, Michigan.
Footnotes available in notes section. Source: National Newborn Screening and Genetics Resource Center. Retrieved May 14, 2014, from
- Genetic Testing - - Genetic Counseling - - Genetic Therapy - By: Austin Justin Amanda Brie.
Newborn Screening in Washington Cristine M Trahms, MS, RD, FADA Center on Human Development and Disability Division of Genetics and Development Department.
Genetic testing: Past, present, future
The Newborn Screening System
Common Thyroid Disorders in Children
MAPLE SYRUP URINE DISEASE (MSUD) IS A METABOLISM DISORDER PASSED DOWN THROUGH FAMILIES IN WHICH THE BODY CANNOT BREAK DOWN CERTAIN PARTS OF PROTEINS. URINE.
EMGO Institute for Health and Care Research Quality of Care Martina Cornel, MD, PhD Professor of community genetics & public health genomics Genetic screening.
Pregnancy & Newborn Screening Developments Medium Chain Acyl CoA Dehydrogenase Deficiency (MCADD)
Adults with Inborn Errors of Metabolism Farrah Rajabi, MD Clinical Genetics Fellow Boston Children’s Hospital New England Genetics Collaborative Annual.
Newborn Screening and Children’s Special Health Care Services
Continuity Clinic The Exciting, Emotional and often Misunderstood World of.
NEWBORN SCREENING IN PAKISTAN When & How ?
I have no relevant financial relationships with the manufacturers of any commercial products and/or provider of commercial services discussed in this CME.
1 Meeting Children’s Special Food and Nutrition Needs in Child Nutrition Programs Lesson 4: Understanding Inborn Errors of Metabolism Define inborn errors.
Fatty Acid Oxidation Defects
Individual amino acids metabolism of clinical importance ط Overview of synthesis of some important products of amino acids : Phenylalanine, Tyrosine, Tryptophane,
From newborn screening to preconception care: PKU mothers and their offspring Violanda Grigorescu, MD, MSPH, William Young, PhD, Karen Andruszewski, MA,
1 Meeting Children’s Special Food and Nutrition Needs in Child Nutrition Programs Lesson 4: Understanding Inborn Errors of Metabolism Define inborn errors.
Oxidation of Fatty Acids. BIOMEDICAL IMPORTANCE Oxidation in – Mitochondria Biosynthesis in – Cytosol Utilizes NAD + and FAD as coenzymes generates ATP.
FATTY ACID OXIDATION. OBJECTIVES FATTY ACID OXIDATION Explain fatty acid oxidation Illustrate regulation of fatty acid oxidation with reference to its.
Fatty acid catabolism 1.Digestion, Mobilization, and Transport of Fatty acids  Oxidation 3. Ketone Bodies.
Introduction Organ Transplantation Program Update Advisory Committee on Organ Transplantation November 17, 2015 Melissa Greenwald, MD Acting Director Division.
Genetic testing: Past, present, future. What is Genetic Testing? A genetic test is the analysis of human DNA, RNA, chromosomes, proteins, or metabolites.
NEWBORN SCREENING Greg Enns, MB, ChB, FAAP Professor of Pediatrics
TEXAS NEWBORN SCREEN PRESENTED BY: SHAYNA BAUMAN & ROSA CARRANZA UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON ADVANCED NEONATAL HEALTH ASSESSMENT GNRS.
Newborn screening Doc. MUDr. Marie Černá, CSc. Lecture No 423-H.
Bruno Sopko. Genetics Biochemistry Clinical medicine.
University of Nevada Reno Division of Health Sciences Nevada State Public Health Laboratory Newborn Screening (NBS) Program.
University of Nevada Reno Division of Health Sciences Nevada State Public Health Laboratory Newborn Screening (NBS) Program.
Practical aspects of implementing neonatal screening programmes EURORDIS conference Dubrovnik, 31 May 2013 Martina C Cornel Professor of Community Genetics.
Metabolism of dietary lipids Biochemistry Department.
MCADD, caused by mutation in the ACADM gene is the most common disorder of fatty acid  - oxidation. Treatment is very successfully if started before symptoms.
BIOCHEMICAL BASIS OF BONE AND MUSCLE DISEASES
Date of download: 7/2/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Adrenergic-Fatty Acid Load in Heart Failure J.
Neonatal screening programs: Should parents be given a choice of screening options? Marcel Verweij Ethics Institute, Utrecht University NL.
Oxidation of Fatty Acid
NEONATAL SCREENING M.Prasad Naidu MSc Medical Biochemistry,
Volume 74, Issue 1, Pages (January 2010)
An Approach to Inborn Errors of Metabolism
NEWBORN SCREENING IN THE UK
آشنایی با انواع شیرخشک. آشنایی با انواع شیرخشک.
SURVEY OF BIOCHEMISTRY Fatty Acid Oxidation
Rhabdomyolysis Caused by an Inherited Metabolic Disease: Very Long-chain Acyl-CoA Dehydrogenase Deficiency  Nicol C. Voermans, MD, Baziel G. van Engelen,
The Association Between Acute Fatty Liver of Pregnancy and Fatty Acid Oxidation Disorders  Patricia A. Jamerson  Journal of Obstetric, Gynecologic & Neonatal.
Paediatric fatty liver disease (PeFLD): All is not NAFLD – Pathophysiological insights and approach to management  Robert Hegarty, Maesha Deheragoda,
Future Role of the Advanced Practitioner with Adult Metabolic Medicine
A.S. Grice, T.E. Peck  British Journal of Anaesthesia 
Russell K. Soon, Jim S. Yan, James P. Grenert, Jacquelyn J. Maher 
Nat. Rev. Endocrinol. doi: /nrendo
Presentation transcript:

Region 4 Genetics Collaborative NCC/RC Annual Meeting November 17, 2009 Region 4 Genetics Collaborative Long-term Follow-up Projects

Region 4 Genetics Collaborative NCC/RC Annual Meeting November 17, 2009 Inborn Errors of Metabolism Information System (IBEM-IS) Project Lead Susan Berry, MD

Region 4 Genetics Collaborative NCC/RC Annual Meeting November 17, 2009 IBEM-IS Goal –To gather uniform data and asses clinical practice differences to learn which treatment strategies are most effective Product –Disease registry to track treatment and outcomes of patients

Region 4 Genetics Collaborative NCC/RC Annual Meeting November 17, 2009 Current Scope Elements defined for 33 genetic conditions –All fatty acid oxidation disorders –Maple Syrup Urine Disease and Tyrosenemia –C3; C5OH disorders; and GA-1 –Biotinidase and Glactosemia

Region 4 Genetics Collaborative NCC/RC Annual Meeting November 17, 2009 Clinics Participating Project Participation –9 Region 4 clinics –2 Heartland clinics Pending IRB approval –1 Region 4 Clinic –1 Heartland Clinic

Region 4 Genetics Collaborative NCC/RC Annual Meeting November 17, 2009 Cases Entered Total subjects = 135 Carnitine Uptake Disorder (CUD) Carnitine palmitoyltransferase (CPT 1 & 2) isobutyryl-CoA dehydrogenase (IBD) deficiency Long-chain hydroxyacyl-CoA dehydrogenase (LCHAD) Medium-chain acyl-coenzyme dehydrogenase (MCAD) Maple Syrup Urine Disease – Short chain acyl CoA dehydrogenase deficiency (SCAD) – Tri-functional protein deficiency (TFP) Very-long chain acyl-CoA dehydrogenase deficiency (VLCAD) Carnitine Update Disorder (CUD) Carnitine Palmitoyl transferase Deficiency 1 / 2 (CPT)

Region 4 Genetics Collaborative NCC/RC Annual Meeting November 17, 2009 New Developments Companion surveys under development: Dialysis Imaging Pregnancy Transplant

Region 4 Genetics Collaborative NCC/RC Annual Meeting November 17, 2009 Congenital Adrenal Hyperplasia Long-term Follow-up Project Lead Kyriakie Sarafoglou, M.D.

Region 4 Genetics Collaborative NCC/RC Annual Meeting November 17, 2009 Benefits Provide valuable information on a broader scale than can be obtained at a single institution Catalyst to create collaborative research projects Examine effect of “stigma” on CAH patients Better methods of monitoring disease control Improved understanding of the disease course and ways to improve outcomes

Region 4 Genetics Collaborative NCC/RC Annual Meeting November 17, 2009 Current Status CAH surveys complete and entered into DocSite platform DSD surveys drafted Urogenital surveys drafted